Compounds > cabergoline
Page last updated: 2024-08-23

cabergoline and Pulmonary Fibrosis

cabergoline has been researched along with Pulmonary Fibrosis in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (83.33)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arduc, A; Berker, D; Çiçekcioğlu, H; Demirci, N; Demirtaş, S; Doğan, BA; Güler, S; Tuna, MM1
Andersohn, F; Garbe, E1
MacIver, DH; Townsend, M1
Baran, AS; Rack, MJ; Richert, AC; Roffwarg, HP1
Basu, S; Chaudhuri, KR; Dhawan, V; Jackson, G; Luce, P; Medcalf, P; Odin, P; Stegie, F1
Burger, E; Härtter, S; Kvernmo, T1

Reviews

1 review(s) available for cabergoline and Pulmonary Fibrosis

ArticleYear
A review of the receptor-binding and pharmacokinetic properties of dopamine agonists.
    Clinical therapeutics, 2006, Volume: 28, Issue:8

    Topics: Animals; Bromocriptine; Cabergoline; Dopamine Agonists; Drug Interactions; Dyskinesia, Drug-Induced; Ergolines; Heart Valve Diseases; Humans; Indoles; Pergolide; Pulmonary Fibrosis; Receptors, Dopamine

2006

Other Studies

5 other study(ies) available for cabergoline and Pulmonary Fibrosis

ArticleYear
Autoimmune Fibrotic Adverse Reactions in One-Year Treatment with Cabergoline for Women with Prolactinoma.
    Endocrine, metabolic & immune disorders drug targets, 2016, Volume: 16, Issue:1

    Topics: Adult; Cabergoline; Dopamine Agonists; Ergolines; Female; Follow-Up Studies; Heart Diseases; Humans; Prolactinoma; Prospective Studies; Pulmonary Fibrosis; Time Factors; Treatment Outcome; Young Adult

2016
Cardiac and noncardiac fibrotic reactions caused by ergot-and nonergot-derived dopamine agonists.
    Movement disorders : official journal of the Movement Disorder Society, 2009, Jan-15, Volume: 24, Issue:1

    Topics: Aged; Aged, 80 and over; Apomorphine; Benzothiazoles; Bromocriptine; Cabergoline; Databases, Factual; Dopamine Agonists; Endomyocardial Fibrosis; Ergolines; Female; Fibrosis; Heart Valve Diseases; Humans; Indoles; Male; Middle Aged; Pergolide; Pericarditis; Pleural Diseases; Pramipexole; Pulmonary Fibrosis; Retroperitoneal Fibrosis; Tetrahydronaphthalenes; Thiophenes; United States

2009
Constrictive pericarditis and pleuropulmonary fibrosis secondary to cabergoline treatment for Parkinson's disease.
    Heart (British Cardiac Society), 2004, Volume: 90, Issue:8

    Topics: Antiparkinson Agents; Cabergoline; Ergolines; Fibrosis; Humans; Male; Middle Aged; Parkinson Disease; Pericarditis, Constrictive; Pleura; Pulmonary Fibrosis

2004
Cardiopulmonary complications of ergot-derivative dopamine agonists.
    The Journal of clinical psychiatry, 2004, Volume: 65, Issue:10

    Topics: Antipsychotic Agents; Bromocriptine; Cabergoline; Dopamine Agonists; Dose-Response Relationship, Drug; Ergolines; Heart Valve Diseases; Humans; Hyperprolactinemia; Pergolide; Pulmonary Fibrosis; Risperidone

2004
Retrospective evaluation of cardio-pulmonary fibrotic side effects in symptomatic patients from a group of 234 Parkinson's disease patients treated with cabergoline.
    Journal of neural transmission (Vienna, Austria : 1996), 2005, Volume: 112, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Cabergoline; Ergolines; Female; Fibrosis; Heart Valve Diseases; Humans; Male; Middle Aged; Parkinson Disease; Pulmonary Fibrosis; Retroperitoneal Fibrosis; Retrospective Studies

2005